Lantern Pharma Inc. (LTRN) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $4.42M | -41.1% |
| 2024 | $7.51M | -65.8% |
| 2023 | $21.94M | -41.0% |
| 2022 | $37.20M | -27.8% |
| 2021 | $51.52M | +167.9% |
| 2020 | $19.23M | +1460.8% |
| 2019 | $1.23M | +176.8% |
| 2018 | $445.2K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $4.42M | -41.1% |
| 2024 | $7.51M | -65.8% |
| 2023 | $21.94M | -41.0% |
| 2022 | $37.20M | -27.8% |
| 2021 | $51.52M | +167.9% |
| 2020 | $19.23M | +1460.8% |
| 2019 | $1.23M | +176.8% |
| 2018 | $445.2K | — |